CASI Pharmaceuticals (United States)
- Research works
- 117 ◆ 0% vs 2013–17
- Citations
- 6.5k 55.1 per fractional work
- Top-10% rate
- 14.1% record average 16.5%
- Open access
- 30% world 28%
Not ranked overall: CASI Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Health Professions, 3.1×. Every wedge is a field page.
- Health Professions 3.1×
- Medicine 2.0×
- Social Sciences 2.0×
- Biochemistry, Genetics and Molecular Biology 2.0×
- Neuroscience 1.7×
- Psychology 1.6×
- Immunology and Microbiology 1.4×
- Earth and Planetary Sciences 1.0×
- Economics, Econometrics and Finance 0.7×
- Arts and Humanities 0.4×
- Engineering 0.2×
- Agricultural and Biological Sciences 0.2×
Who are the top researchers at CASI Pharmaceuticals (United States)?
Ranked on the composite score, Theresa LaVallee lead among researchers whose main affiliation is CASI Pharmaceuticals (United States).
- 1 Theresa LaVallee United States · #1,209,413 worldwide 53 citations · 38 works
Which keywords describe research at CASI Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Breast Cancer, Cancer, Cancer Therapy, Signaling, endothelial progenitor cells, VEGF and Receptor.
- Peptide Synthesis
- Cancer Progression
- Microtubules
- Cell Division
- Fc Receptors
- Warburg Effect
- HIF-1
- Protein-Protein Interactions
- Apoptosis
- Drug Discovery
- Tumor Microenvironment
- Cell Signaling
- Chemotherapy
- Glucocorticoids
- Estrogen
- Angiogenesis
- endothelial progenitor cells
- Signaling
- Breast Cancer
- Cancer
- Inflammation
- Epidemiology
- Cancer Therapy
- VEGF
- Receptor
- Transcriptional Regulation
- Nuclear Receptors
- Tamoxifen
- Vaccine Development
- Metabolism
- Glycosylation
- Immunotherapy
- Immunity
- Innate Immunity
- Pharmacology
- Extracellular Matrix
- Therapeutic Antibodies
- Insecticide Resistance
- Artemisinin Resistance
- Foldamers
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation10▲ 3.7×28 topics
- Cancer8▲ 4.9×19 topics
- Epidemiology8▲ 1.59×20 topics
- Breast Cancer7▲ 21×7 topics
- Cancer Therapy6▲ 8.3×10 topics
- Signaling6▲ 45×4 topics
- VEGF6▲ 146×1 topic
- endothelial progenitor cells6▲ 146×1 topic
- Receptor6▲ 66×2 topics
- Angiogenesis5▲ 11×8 topics
- Transcriptional Regulation5▲ 17×3 topics
- Estrogen5▲ 56×2 topics
- Nuclear Receptors5▲ 23×3 topics
- Glucocorticoids4▲ 68×1 topic
- Tamoxifen4▲ 68×1 topic
- Chemotherapy4▲ 5.2×11 topics
- Vaccine Development4▲ 12×4 topics
- Cell Signaling4▲ 10×6 topics
- Metabolism4▲ 5.1×10 topics
- Tumor Microenvironment4▲ 9.5×5 topics
- Glycosylation4▲ 15×3 topics
- Drug Discovery4▲ 8.0×5 topics
- Immunotherapy4▲ 4.7×9 topics
- Apoptosis4▲ 7.6×8 topics
- Immunity3▲ 8.2×7 topics
- Protein-Protein Interactions3▲ 25×2 topics
- Innate Immunity3▲ 7.4×7 topics
- HIF-13▲ 34×1 topic
- Pharmacology3▲ 7.5×6 topics
- Warburg Effect3▲ 34×1 topic
- Extracellular Matrix3▲ 9.7×3 topics
- Fc Receptors3▲ 22×1 topic
- Therapeutic Antibodies3▲ 17×1 topic
- Cell Division2▲ 59×1 topic
- Insecticide Resistance2▲ 22×2 topics
- Microtubules2▲ 59×1 topic
- Artemisinin Resistance2▲ 53×1 topic
- Cancer Progression2▲ 9.1×5 topics
- Foldamers2▲ 26×1 topic
- Peptide Synthesis2▲ 26×1 topic
Which research topics does CASI Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Education Pedagogy and Practices, Diabetes Management and Research, Cholinesterase and Neurodegenerative Diseases and Mobile Health and mHealth Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Education Pedagogy and Practices Education 0 works
- 2 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
- 3 Cholinesterase and Neurodegenerative Diseases Pharmacology 0 works
- 4 Mobile Health and mHealth Applications General Health Professions 0 works
- 5 Diabetes Management and Education Endocrinology, Diabetes and Metabolism 0 works
- 6 Alzheimer's disease research and treatments Physiology 0 works
- 7 Biochemical and Structural Characterization Molecular Biology 0 works
- 8 Religious Tourism and Spaces Geography, Planning and Development 0 works
- 9 Youth, Drugs, and Violence Demography 0 works
- 10 Science and Education Research Education 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has CASI Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 0% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Rockville
- United States Nuclear Regulatory Commission
- Signal Processing (United States)
- Center for Devices and Radiological Health
- Agency for Healthcare Research and Quality
- Orthopaedic Center
- Biomedical Research Institute
- Westat (United States)
- Research Applications (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.